SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-032224
Filing Date
2022-06-10
Accepted
2022-06-10 16:03:48
Documents
13
Period of Report
2022-06-08
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea161387-8k_emmauslife.htm   iXBRL 8-K 28669
2 LETTER DATED JUNE 8, 2022 TO THE BOARD OF DIRECTORS OF EMMAUS LIFE SCIENCES, INC ea161387ex99-1_emmauslife.htm EX-99.1 5167
  Complete submission text file 0001213900-22-032224.txt   204212

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE emma-20220608.xsd EX-101.SCH 2989
4 XBRL LABEL FILE emma-20220608_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE emma-20220608_pre.xml EX-101.PRE 22379
7 EXTRACTED XBRL INSTANCE DOCUMENT ea161387-8k_emmauslife_htm.xml XML 3291
Mailing Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503
Business Address 21250 HAWTHORNE BOULEVARD, SUITE 800 TORRANCE CA 90503 310-214-0065
Emmaus Life Sciences, Inc. (Filer) CIK: 0000822370 (see all company filings)

IRS No.: 870419387 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35527 | Film No.: 221008825
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences